NFGH
MIRM icon

Nan Fung Group Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

Nan Fung Group Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-146,765
Closed -$6.61M – 27
2025
Q1 		$6.61M Buy
146,765
+21,435
+17% +$1.01M 5.39% 6
2024
Q4 		$5.18M Buy
125,330
+19,230
+18% +$801K 4.43% 6
2024
Q3 		$4.14M Hold
106,100
– – 3.57% 12
2024
Q2 		$3.63M Buy
106,100
+10,000
+10% +$262K 3.87% 10
2024
Q1 		$2.41M Hold
96,100
– – 2.24% 14
2023
Q4 		$2.84M Buy
+96,100
New +$2.91M 1.77% 11

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nan Fung Group Holdings's MIRM Position: Q2 2025 in Review

Nan Fung Group Holdings sold out of Mirum Pharmaceuticals (MIRM) in Q2 2025, closing a stake of 146,765 shares — an estimated $6.61M sold.

Nan Fung Group Holdings first reported a position in MIRM in Q4 2023 and held it in 6 quarters. The position peaked at $6.61M in Q1 2025. 214 funds tracked by Wall St. Rank hold MIRM as of Q2 2025.

  • Nan Fung Group Holdings reported no remaining Mirum Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Nan Fung Group Holdings sold 146,765 Mirum Pharmaceuticals shares in Q2 2025, an estimated $6.61M.
  • Nan Fung Group Holdings first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Nan Fung Group Holdings's Mirum Pharmaceuticals position peaked at $6.61M in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2025.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.